Efficacy, Safety and Pharmacokinetics of Teriflunomide in Pediatric Patients With Relapsing Forms of Multiple Sclerosis

Investigational Site Number : 807001, Skopje

Investigational Site Number : 100001, Sofia

Investigational Site Number : 807002, Shtip

Investigational Site Number : 788001, Manouba

Investigational Site Number : 056001, Leuven

Investigational Site Number : 788002, Sfax

Investigational Site Number : 788004, Sfax

Investigational Site Number : 056002, Ghent

Investigational Site Number : 233001, Tallinn

Investigational Site Number : 688002, Belgrade

Raleigh Neurology Associates Site Number : 840004, Raleigh

Investigational Site Number : 724002, Murcia

Investigational Site Number : 250005, Toulouse

Investigational Site Number : 792006, Istanbul

Investigational Site Number : 792003, Istanbul

Investigational Site Number : 250003, Rennes

North Central Neurology Associates, PC Site Number : 840003, Cullman

Investigational Site Number : 792008, Izmir

Investigational Site Number : 504005, Marrakesh

Investigational Site Number : 440001, Kaunas

Investigational Site Number : 376003, Tel Litwinsky

Investigational Site Number : 300001, Thessaloniki

Investigational Site Number : 804001, Kharkiv

Investigational Site Number : 804002, Kharkiv

Investigational Site Number : 250002, Lyon

Investigational Site Number : 376001, Jerusalem

Investigational Site Number : 250001, Le Kremlin-Bicêtre

Investigational Site Number : 156001, Beijing

Investigational Site Number : 156002, Beijing

Investigational Site Number : 156010, Beijing

Investigational Site Number : 643001, Moscow

Investigational Site Number : 156006, Changchun

Investigational Site Number : 643005, Saint Petersburg

Investigational Site Number : 643002, Saint Petersburg

Investigational Site Number : 156003, Shanghai

Investigational Site Number : 156004, Shanghai

Investigational Site Number : 156005, Chongqing

Investigational Site Number : 156007, Changsha

Investigational Site Number : 156012, Guangzhou

Investigational Site Number : 643003, Nizhny Novgorod

Investigational Site Number : 156008, Chengdu

Investigational Site Number : 643004, Novosibirsk

Axiom Clinical Research of Florida Site Number : 840012, Tampa

Massachusetts General Hospital Site Number : 840002, Boston

Investigational Site Number : 124001, Calgary

Investigational Site Number : 156011, Shijiazhuang

Investigational Site Number : 156009, Taiyuan

Investigational Site Number : 300002, Athens

Investigational Site Number : 422001, Beirut

Investigational Site Number : 504004, Fes

Investigational Site Number : 792007, Izmir

Investigational Site Number : 528001, Rotterdam

Investigational Site Number : 620001, Coimbra

Investigational Site Number : 792002, Ankara

Investigational Site Number : 792001, Ankara

Investigational Site Number : 826001, London

Investigational Site Number : 826003, Birmingham